Development and Validation of a Nomogram for Predicting Response to TACE Combined with Lenvatinib and Anti-PD-1 Therapy in Unresectable Hepatocellular Carcinoma
We developed and validated a non-invasive nomogram that integrates readily available clinical and imaging features to effectively predict treatment response to triple therapy in u-HCC patients. This tool holds potential for personalizing treatment strategies and improving prognostic assessment.
Authors
- Ying Nian Wu
- Linhui Li
- Jiandong Shen
- Yanjun Sun
- Xing Wang
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Yancheng First People's Hospital (CN)
- Yancheng Third People's Hospital (CN)
- Changzhou Third People's Hospital (CN)
- Wuxi Taihu Hospital (CN)
- Wuxi People's Hospital (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2026-02-01
- DOI
- https://doi.org/10.2147/jhc.s580139
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00